Get started
KUROS BIOSCIENCES LTDKUROS BIOSCIENCES LTDKUROS BIOSCIENCES LTD

KUROS BIOSCIENCES LTD

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

YTSN chart


Full chart

YTSN upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪1.11 B‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.12 EUR
Net income (FY)
‪−4.56 M‬ EUR
Revenue (FY)
‪80.36 M‬ EUR
Shares float
‪26.32 M‬
Beta (1Y)
1.36

Employees


Employees (FY)
4
Change (1Y)
−1 −20.00%
Revenue / Employee (1Y)
‪20.09 M‬ EUR
Net income / Employee (1Y)
‪−988.10 K‬ EUR

About KUROS N


Sector
Health Technology
Industry
Biotechnology
CEO
Christopher T. Fair
Website
kurosbio.com
Headquarters
Schlieren
Founded
2000
ISIN
CH0325814116
FIGI
BBG000FG66R8
Kuros Biosciences Ltd. operates as biopharmaceutical company, which engages in developing products for tissue repair and bone regeneration. It operates through the following segments: Medical devices, Pharmaceuticals, and Legacy portfolio. The Medical devices segment includes products such as MagnetOs and Attrax. The Pharmaceuticals segment offers Fibrin-PTH, a drug-biologic combination which promotes targeted and controlled bone formation through the induction of osteoprogenitor cell differentiation, enhancement, of osteoblast proliferation and by increasing the lifespan of bone-forming cells. The Legacy portfolio segment is involved in all other products that do not belong to the group's core business strategy. The company was founded by Didier Cowling in 2000 and is headquartered in Schlieren, Switzerland.

Check out other big names from the same industry as YTSN.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

YTSN news



Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of YTSN is 30.38 EUR — it has increased by 1.06% in the past 24 hours. Watch KUROS BIOSCIENCES LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange KUROS BIOSCIENCES LTD stocks are traded under the ticker YTSN.
YTSN stock has risen by 4.04% compared to the previous week, the month change is a 6.75% rise, over the last year KUROS BIOSCIENCES LTD has showed a 431.12% increase.
We've gathered analysts' opinions on KUROS BIOSCIENCES LTD future price: according to them, YTSN price has a max estimate of 34.46 EUR and a min estimate of 28.63 EUR. Watch YTSN chart and read a more detailed KUROS BIOSCIENCES LTD stock forecast: see what analysts think of KUROS BIOSCIENCES LTD and suggest that you do with its stocks.
YTSN reached its all-time high on Jun 16, 2025 with the price of 30.94 EUR, and its all-time low was 2.10 EUR and was reached on Sep 27, 2023. View more price dynamics on YTSN chart.
See other stocks reaching their highest and lowest prices.
YTSN stock is 4.34% volatile and has beta coefficient of 1.36. Track KUROS BIOSCIENCES LTD stock price on the chart and check out the list of the most volatile stocks — is KUROS BIOSCIENCES LTD there?
Today KUROS BIOSCIENCES LTD has the market capitalization of ‪1.17 B‬, it has decreased by −2.70% over the last week.
Yes, you can track KUROS BIOSCIENCES LTD financials in yearly and quarterly reports right on TradingView.
KUROS BIOSCIENCES LTD is going to release the next earnings report on Aug 13, 2025. Keep track of upcoming events with our Earnings Calendar.
KUROS BIOSCIENCES LTD revenue for the last half-year amounts to ‪46.48 M‬ EUR, despite the estimated figure of ‪48.18 M‬ EUR. In the next half-year revenue is expected to reach ‪57.46 M‬ EUR.
YTSN net income for the last half-year is ‪−4.34 M‬ EUR, while the previous report showed ‪−219.11 K‬ EUR of net income which accounts for ‪−1.88 K‬% change. Track more KUROS BIOSCIENCES LTD financial stats to get the full picture.
No, YTSN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jul 12, 2025, the company has 4 employees. See our rating of the largest employees — is KUROS BIOSCIENCES LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. KUROS BIOSCIENCES LTD EBITDA is ‪2.73 M‬ EUR, and current EBITDA margin is 3.40%. See more stats in KUROS BIOSCIENCES LTD financial statements.
Like other stocks, YTSN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KUROS BIOSCIENCES LTD stock right from TradingView charts — choose your broker and connect to your account.